交银国际每日晨报-20251016

Group 1: Legendary Biotech (LEGN US) - 3Q25 Carvykti sales reached $524 million, exceeding expectations with a year-on-year growth of 84% and a quarter-on-quarter growth of 19% [1] - The U.S. market contributed $396 million in sales, reflecting a year-on-year increase of 53% and a quarter-on-quarter increase of 11%, while international sales reached $128 million, up 374% year-on-year and 58% quarter-on-quarter [1] - Johnson & Johnson reaffirmed its peak sales target for Carvykti at over $5 billion, expressing increased confidence in achieving this goal [1][2] Group 2: Internet Industry - Tencent's domestic mobile game revenue decreased by $2.7 billion (8%) year-on-year, primarily due to high base effects from the previous year, although new games partially offset this decline [4] - Tencent's overseas revenue increased by $670 million (9%) year-on-year, driven by new game releases like Clash Royale [4] - NetEase's domestic revenue showed a slight increase of $0.7 million (1%), while overseas revenue grew by $1.6 million (18%) due to contributions from new games [4] Group 3: Battery Industry - In September 2025, China's domestic power battery installation volume reached 76.0 GWh, marking a year-on-year increase of 39.5% and a month-on-month increase of 21.6% [7] - Battery exports remained robust, totaling 26.7 GWh in September, with a year-on-year increase of 28.3% [7] - China's export controls on certain lithium battery materials and equipment are expected to improve the competitive landscape overseas, potentially enhancing profitability for leading companies with overseas production capabilities [7][8] Group 4: Pharmaceutical Industry - The Hang Seng Healthcare Index fell by 12.0% this week, underperforming the broader market, with traditional Chinese medicine and internet healthcare sectors showing relatively better performance [9] - Institutions have been increasing their positions in high-value innovative drug stocks, despite a slight decrease in holdings of pharmaceutical stocks through the Hong Kong Stock Connect [9][10] - The upcoming ESMO conference is anticipated to provide significant data releases, with recommendations to focus on companies like CanSino Biologics and Hengrui Medicine [10]